Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT00050154 · COMPLETED
Trial details
- NCT number
- NCT00050154
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.